The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial

Abstract Background Current guidelines recommend intensive low-density lipoprotein (LDL) cholesterol lowering with statins, with a target of 70 mg/dL (1.81 mmol/L) LDL cholesterol for those with a very high risk of coronary artery events. However, there is no multicenter study assessing the effect o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Atherosclerosis 2014-04, Vol.233 (2), p.707-712
Hauptverfasser:	Zhao, Shui-ping, Yu, Bi-lian, Peng, Dao-quan, Huo, Yong
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndrome Acute Coronary Syndrome - blood Acute Coronary Syndrome - drug therapy Aged Atorvastatin C-Reactive Protein - analysis Cardiovascular Cardiovascular Agents - therapeutic use China Cholesterol, LDL - blood Dose-Response Relationship, Drug Drug Therapy, Combination Endpoint Determination Female Heptanoic Acids - administration & dosage Heptanoic Acids - adverse effects Heptanoic Acids - therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use LDL cholesterol Lipid-lowering Lipids - blood Male Middle Aged Prospective Studies Pyrroles - administration & dosage Pyrroles - adverse effects Pyrroles - therapeutic use Statins Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!